US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

102.50

-0.7073-0.69%

Post-market: 102.36-0.1428-0.14%19:30 EDT

Volume:18.72K

Turnover:1.92M

Market Cap:128.12M

PE:- -

High:103.87

Open:103.87

Low:102.00

Close:103.21

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:1.09

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes

BetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program

Lakefront Biotherapeutics granted orphan drug designation for gamgertamig

Birikim Varlık Yönetim Sets First Coupon Rate on TLREF-Linked Financing Bill

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

Ichigo Hotel REIT Sets Rates on JPY 8.2 Billion in New Loans

If Rising Rates were Enough to End a Bull Market, We'd Have Entered a Bear Market Long Ago

Regeneron’s Pasatru granted FDA approval for FOP

LabGenomics Lowers Conversion Price on Fifth Tranche of Convertible Bonds

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

Arovella lodges 2026 corporate governance statement and Appendix 4G

Press Release: Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

Aurinia settles patent litigation with Teva

Marvel Biosciences Extends Private Placement Access to Quebec Investors

Femasys announces FDA approval of FemBloc modular premarket approval application

Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback

Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G

Amylyx Phase 3 data support FDA approval, says Citi

Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning

Coherus Oncology issuing special dividend of biosimilar contingent value rights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BBP/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":102.4978,"timestamp":1790971200000,"preClose":103.2051,"halted":0,"volume":18715,"hourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"delay":0,"changeRate":-0.0068533434878703045,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":-0.7073,"latestTime":"10-02 16:00:00 EDT","open":103.87,"high":103.87,"low":102.0005,"amount":1918982.2008,"amplitude":0.018114,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.2051,"sharesOutstanding":600004,"nav":102.494,"aum":128117601.53,"bidAskSpread":0.002439,"postHourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"volumeRatio":1.0888030521127026,"impliedVol":0.2277,"impliedVolPercentile":0.4462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0888030521127026,"shares":1250004,"dividePrice":0,"high":103.87,"amplitude":0.018114,"preClose":103.2051,"low":102.0005,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":102.4978,"eps":0,"divideRate":0,"volume":18715,"delay":0,"ttmEps":0,"open":103.87,"prevYearClose":79.9149,"prevWeekClose":104.6582,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":104.6582,"twentyDayClose":108.8566,"sixtyDayClose":103.6198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662578669","title":"Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662578669","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662578669?lang=en_us&edition=fundamental","pubTime":"2026-08-25 13:27","pubTimestamp":1787635670,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Terragen Holdings Ltd ( ($AU:TGH) ). Terragen Holdings Limited, an agricultural biotechnology company, develops...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/terragen-posts-wider-loss-as-revenue-falls-and-asset-backing-erodes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/terragen-posts-wider-loss-as-revenue-falls-and-asset-backing-erodes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","XT","AGNG","FWD","SYNB","BK4585","IEIH","JDOC","FHLC","IBB","BBP","LNGR","DARP","IVEG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662404204","title":"BetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662404204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662404204?lang=en_us&edition=fundamental","pubTime":"2026-08-25 08:02","pubTimestamp":1787616148,"startTime":"0","endTime":"0","summary":"BetterLife Pharma ( ($TSE:BETR) ) has issued an update. BetterLife Pharma Inc., a Vancouver-based biotechnology company, is focused on developing B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/betterlife-pharma-plans-equity-offering-to-advance-neurological-trial-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/betterlife-pharma-plans-equity-offering-to-advance-neurological-trial-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","EQR","FWD","XT","RSPH","BK4215","FHLC","IEIH","JDOC","BK4588","LNGR","DARP","REZ","BBP","SYNB","BK4585","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206528","title":"Lakefront Biotherapeutics granted orphan drug designation for gamgertamig","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206528","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206528?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602240,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutic (LKFT) announced that the FDA has granted orphan drug designation to gamgertamig for the treatment of pemphigus. Gamgertam...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakefront-biotherapeutics-granted-orphan-drug-designation-for-gamgertamig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakefront-biotherapeutics-granted-orphan-drug-designation-for-gamgertamig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4588","BK4139","LKFT","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661929195","title":"Birikim Varlık Yönetim Sets First Coupon Rate on TLREF-Linked Financing Bill","url":"https://stock-news.laohu8.com/highlight/detail?id=2661929195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661929195?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:47","pubTimestamp":1787327249,"startTime":"0","endTime":"0","summary":"Birikim Varlik Yonetim A.S. ( ($TR:BRKVY) ) just unveiled an update. Birikim Varlık Yönetim A.Ş. has disclosed the interest rates for the first cou...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/birikim-varlik-yonetim-sets-first-coupon-rate-on-tlref-linked-financing-bill?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/birikim-varlik-yonetim-sets-first-coupon-rate-on-tlref-linked-financing-bill?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRSH","07366","TSDD","DFUV","TSLY","UCC","TSL","TSLL","09366","TSYY","TSLW","TSLR","TSLP","TESL","09766","VAW","KOMP","ELOL","CAOS","BK4585","BK4588","PEVC","TSII","LRCY","TSLO","FXL","TSLZ","IJK","CLIX","TSLI","RJZ","ANEW","07766","TSLG","AVSD","TESC","TEST","TSLS","BBP","TSLQ","CGDV","TSLT","TLA","FXR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU2468319806.SGD","SYNB","BBP","LU2023250504.SGD","RSPH","REGN","LU0053666078.USD","FWD","LU0889565916.HKD","LU0114720955.EUR","LNGR","LU1917777945.USD","LU1974910355.USD","BK4588","LU2362541513.USD","IBBQ","LU2237438978.USD","LU0823434583.USD","FHLC","DARP","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","XT","BK4139","LU2362541273.HKD","LU0109394709.USD","JDOC","AGNG","BBH","LU0882574055.USD","LU0823416689.USD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661125053","title":"Ichigo Hotel REIT Sets Rates on JPY 8.2 Billion in New Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2661125053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661125053?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:53","pubTimestamp":1787295222,"startTime":"0","endTime":"0","summary":"Ichigo Hotel REIT Investment Corp. ( ($JP:3463) ) has shared an update. Ichigo Hotel REIT Investment Corporation has set initial interest rates on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ichigo-hotel-reit-sets-rates-on-jpy-8-2-billion-in-new-loans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ichigo-hotel-reit-sets-rates-on-jpy-8-2-billion-in-new-loans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLA","TSLQ","TSLW","RNTY","TESL","ANEW","TSLY","RJMG","TEST","IVRA","UCC","LRCY","TSLR","FXR","TSDD","TSLT","IJK","TSYY","TSLS","TSL","AVSD","CLIX","CGDV","KOMP","TESC","VAW","CAOS","TSLG","MDIV","FXL","TSLP","BBP","TSLL","CRSH","TSLZ","DFRA","BPRE","TSLI","PEVC","IQRA","RJZ","DFUV","ELOL","PSCF","YLDW","07366","REIT","TSII","TSLO","JPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661392262","title":"If Rising Rates were Enough to End a Bull Market, We'd Have Entered a Bear Market Long Ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2661392262","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661392262?lang=en_us&edition=fundamental","pubTime":"2026-08-21 02:03","pubTimestamp":1787248980,"startTime":"0","endTime":"0","summary":"MW If rising rates were enough to end a bull market, we'd have entered a bear market long agoMark HulbertThe 'Fed Model' has turned bearish - should you care?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRCY","UUP","VAW","BOXX","GOVT","CLIX","US3Y.BOND","BIL","HYG","KBE","MINT","RJZ","VGSH","FXL","US7Y.BOND","US5Y.BOND","US2Y.BOND","US10Y.BOND","DFUV","TSLP","TMF","BBP","ANEW","IEI","LQD","VGIT","UCC","BND","AGG","KOMP","VGFPF","SHY","US30Y.BOND","CGDV","FAZ","SCHO","IJK","TBT","CAOS","SHV","UBT","UDN","SKRE","PEVC","AVSD","MUB","US12M.BOND","FXR","TLTW","US6M.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","MRNY","GDOC","IDNA","MEDI","PSCH","IEIH","LABU","XLVX","BK4585","LFSC","SYNB","GNMX","TECB","PINK","TBXU","IBB","IYH","BBP","BK4588","BMED","RSPH","NVIB","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660409357","title":"LabGenomics Lowers Conversion Price on Fifth Tranche of Convertible Bonds","url":"https://stock-news.laohu8.com/highlight/detail?id=2660409357","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660409357?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:41","pubTimestamp":1787208104,"startTime":"0","endTime":"0","summary":"LabGenomics Co., Ltd. ( ($KR:084650) ) just unveiled an update. LabGenomics Co., Ltd., a biotechnology and diagnostics company specializing in geno...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/labgenomics-lowers-conversion-price-on-fifth-tranche-of-convertible-bonds?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/labgenomics-lowers-conversion-price-on-fifth-tranche-of-convertible-bonds?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","XT","RSPH","BMED","BK4588","AGNG","BK4585","FWD","JDOC","FHLC","IEIH","IBB","SYNB","DARP","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028408","title":"Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028408","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:43","pubTimestamp":1787200984,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) just unveiled an announcement. Glenmark Pharmaceuticals has secured U.S. FDA approval for its F...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SYNB","IEIH","FRTY","LABU","TBXU","BBP","BMED","NVIB","MEDI","PSCH","GDOC","IYH","GNMX","IBB","PINK","XLVX","TECB","MRNY","LFSC","IDNA","MRNX","BK4588","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660921472","title":"Arovella lodges 2026 corporate governance statement and Appendix 4G","url":"https://stock-news.laohu8.com/highlight/detail?id=2660921472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660921472?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:37","pubTimestamp":1787189875,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) has shared an announcement. Arovella Therapeutics Limited, an ASX-listed biotechnology company, undersc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-lodges-2026-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-lodges-2026-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ESGY","FDRX","IBB","DARP","SUSA","SYNB","FWD","IEIH","JDOC","AGNG","NUSC","ESML","HAPI","NUDV","LOPP","SSPX","ESGA","BK4588","MDCP","VOTE","HAPY","LNGR","XT","ESGV","JSTC","BBP","PEMX","FHLC","ALA","BK4585","DSI","RSPH","ESG","CHRI","CVLC","CDEI","EXEQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473649","title":"Press Release: Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473649?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:30","pubTimestamp":1787171400,"startTime":"0","endTime":"0","summary":"-- Gross Margin of 54% was broadly level with the same period last year.-- Adjusted EBITDA2 was $46.9 million compared to $53.7 million in the same. -- Cash-balance at the end of the period was $142.8 million compared to. -----------------------------------------  --------  --------  ---------Q2 2026 business highlights-- Alvotech resubmitted US Biologics License Applications for AVT05,proposed biosimilar to Simponi and Simponi Aria and AVT06, proposed. biosimilar to Eylea, following the comprehensive responses to the US. -- Alvotech's partner, Dr. Reddy's Laboratories, resubmitted the US. Biologics License Application for AVT03, proposed biosimilar to. -- FDA confirmed review completion goal dates in alignment with the standard. 6-month process, with decisions anticipated in the fourth quarter of. -- FDA closed its inspection of the company's manufacturing facility in. Reykjavik, conducted in April-May 2026, and confirmed a VAI. -- Alvotech closed an underwritten public offering and p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BBP","BK4139","BK4022","ALVO","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660532473","title":"Aurinia settles patent litigation with Teva","url":"https://stock-news.laohu8.com/highlight/detail?id=2660532473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660532473?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:11","pubTimestamp":1787170262,"startTime":"0","endTime":"0","summary":"Aurinia Pharmaceuticals (AUPH) announced that it and its subsidiary, Aurinia Pharma U.S., Inc., have entered into a settlement agreement with Teva ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aurinia-settles-patent-litigation-with-teva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aurinia-settles-patent-litigation-with-teva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTI","RND","BK4139","MEDX","BBP","USRD","AUPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747836","title":"Marvel Biosciences Extends Private Placement Access to Quebec Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747836?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:08","pubTimestamp":1787166508,"startTime":"0","endTime":"0","summary":"Marvel Biosciences Corp ( ($TSE:MRVL) ) has provided an announcement. Marvel Biosciences Corp. is a Calgary-based pre-clinical biotechnology compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-extends-private-placement-access-to-quebec-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-extends-private-placement-access-to-quebec-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","AGNG","FWD","XT","RSPH","FHLC","BK4211","IEIH","JDOC","BK4588","LNGR","DARP","BBP","SYNB","BK4585","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660252964","title":"Femasys announces FDA approval of FemBloc modular premarket approval application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660252964","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660252964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:16","pubTimestamp":1787145413,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that the FDA has approved the company’s modular premarket approval application pathway for FemBloc, its investigational no...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","RSPH","MEDI","BBP","SYNB","TBXU","FEMY","IYH","BMED","BK4584","BK4539","IDNA","GNMX","GDOC","FRTY","MRNY","PSCH","LABU","TECB","XLVX","BK4585","NVIB","MRNX","IBB","LFSC","BK4588","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184678054","title":"Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184678054","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184678054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:15","pubTimestamp":1787127336,"startTime":"0","endTime":"0","summary":"Andy Acker, Portfolio Manager for healthcare and biotech strategies at Janus Henderson Investors, notes that despite interest rates remaining higher than markets anticipated at the start of the year,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTPE","BIS","BBP","BBC","IBBJ","IYG","FBT","JDOC","IAI","QSML","BK4582","BK4588","MRNX","PBE","IBB","BK4585","IWO","IJT","SPCK","MRNY","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660041502","title":"Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G","url":"https://stock-news.laohu8.com/highlight/detail?id=2660041502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660041502?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:42","pubTimestamp":1787103774,"startTime":"0","endTime":"0","summary":"Percheron Therapeutics ( ($AU:PER) ) just unveiled an announcement. Percheron Therapeutics Limited, an ASX-listed biotechnology company, has publis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-files-asx-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-files-asx-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","LENZ","LNGR","BK4585","BBP","JDOC","BK4588","AGNG","DARP","FWD","SYNB","BK4007","XT","BK4539","IBB","RSPH","BK4139","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660595493","title":"Amylyx Phase 3 data support FDA approval, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660595493","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660595493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061936,"startTime":"0","endTime":"0","summary":"Citi says Amylyx’s (AMLX) avexitide showed a “highly differentiated” profile in the Phase 3 LUCIDITY study, a 78 participant, placebo-controlled tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVIB","GNMX","MRNX","MEDI","IDNA","PINK","BK4588","SYNB","GDOC","BBP","LABU","PSCH","BMED","FRTY","TBXU","TECB","AMLX","MRNY","IYH","XLVX","LFSC","IEIH","IBB","RSPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468019","title":"Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468019?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:33","pubTimestamp":1787041986,"startTime":"0","endTime":"0","summary":"An announcement from Anatara Lifesciences Ltd ( ($AU:ANR) ) is now available. Anatara Lifesciences Ltd is a biotechnology company focused on develo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","XT","FWD","LNGR","BK4585","BK4588","BBP","FHLC","JDOC","DARP","IBB","IEIH","SYNB","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660475437","title":"Coherus Oncology issuing special dividend of biosimilar contingent value rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475437","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:40","pubTimestamp":1787002809,"startTime":"0","endTime":"0","summary":"Coherus Oncology (CHRS) announced a special dividend of contingent value rights which will be distributed on a pro rata basis to stockholders of re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coherus-oncology-issuing-special-dividend-of-biosimilar-contingent-value-rights-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coherus-oncology-issuing-special-dividend-of-biosimilar-contingent-value-rights-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","CHRS","VIG","BK4535","BK4585","BK4139","BK4588","ACTV","ACKY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}